| Description | Efmarodocokin alfa, a fusion protein combining human IL-22 with the IgG4 crystallizable fragment, activates IL-22 signaling. This compound has potential applications in the study of severe COVID-19 pneumonia [1]. |
| molecular weight | N/A |
| CAS | 2247840-74-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |